235 related articles for article (PubMed ID: 25467005)
21. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
Forsythe K; Blacksburg S; Stone N; Stock RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
[TBL] [Abstract][Full Text] [Related]
22. Long-term health-related quality of life after curative treatment for prostate cancer: a regional cross-sectional comparison of two standard treatment modalities.
Hjälm-Eriksson M; Lennernäs B; Ullén A; Johansson H; Hugosson J; Nilsson S; Brandberg Y
Int J Oncol; 2015 Jan; 46(1):381-8. PubMed ID: 25355465
[TBL] [Abstract][Full Text] [Related]
23. Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapy.
Wedlake L; Shaw C; McNair H; Lalji A; Mohammed K; Klopper T; Allan L; Tait D; Hawkins M; Somaiah N; Lalondrelle S; Taylor A; VanAs N; Stewart A; Essapen S; Gage H; Whelan K; Andreyev HJN
Am J Clin Nutr; 2017 Sep; 106(3):849-857. PubMed ID: 28679552
[No Abstract] [Full Text] [Related]
24. Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.
Jereczek-Fossa BA; Santoro L; Zerini D; Fodor C; Vischioni B; Dispinzieri M; Bossi-Zanetti I; Gherardi F; Bonora M; Caputo M; Vavassori A; Cambria R; Garibaldi C; Cattani F; Matei DV; Musi G; De Cobelli O; Orecchia R
J Urol; 2013 Jun; 189(6):2099-103. PubMed ID: 23313200
[TBL] [Abstract][Full Text] [Related]
25. Partnership status affects the association between gastrointestinal symptoms and quality of life after radiation therapy for prostate cancer.
Alsadius D; Olsson C; Wilderäng U; Steineck G
Acta Oncol; 2014 Mar; 53(3):378-84. PubMed ID: 24125102
[TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review.
Adam S; Feller A; Rohrmann S; Arndt V
Health Qual Life Outcomes; 2018 Jan; 16(1):22. PubMed ID: 29361950
[TBL] [Abstract][Full Text] [Related]
27. Health-related quality of life measurement in long-term survivors and outcome following radical radiotherapy for localized prostate cancer.
Galalae RM; Loch T; Riemer B; Rzehak P; Küchler T; Kimmig B; Kovács G
Strahlenther Onkol; 2004 Sep; 180(9):582-9. PubMed ID: 15378189
[TBL] [Abstract][Full Text] [Related]
28. Prospective Phase II Trial of Once-weekly Hypofractionated Radiation Therapy for Low-risk Adenocarcinoma of the Prostate: Late Toxicities and Outcomes.
Zimmermann M; Taussky D; Menkarios C; Vigneault É; Beauchemin MC; Bahary JP; Martin AA; Diaz de Bedoya LV; Lambert C
Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):386-92. PubMed ID: 26782838
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of synbiotics to reduce acute radiation proctitis symptoms and improve quality of life: a randomized, double-blind, placebo-controlled pilot trial.
Nascimento M; Aguilar-Nascimento JE; Caporossi C; Castro-Barcellos HM; Motta RT
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):289-95. PubMed ID: 25304789
[TBL] [Abstract][Full Text] [Related]
30. ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
Rodda S; Morris WJ; Hamm J; Duncan G
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):581-589. PubMed ID: 28581398
[TBL] [Abstract][Full Text] [Related]
31. Early detection and management of symptoms using an interactive smartphone application (Interaktor) during radiotherapy for prostate cancer.
Sundberg K; Wengström Y; Blomberg K; Hälleberg-Nyman M; Frank C; Langius-Eklöf A
Support Care Cancer; 2017 Jul; 25(7):2195-2204. PubMed ID: 28236145
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial.
de Boer SM; Nout RA; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Stenfert Kroese MC; Oerlemans S; Putter H; Verhoeven-Adema KW; Nijman HW; Creutzberg CL
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):797-809. PubMed ID: 26530748
[TBL] [Abstract][Full Text] [Related]
33. Cross-linked hyaluronan gel improves the quality of life of prostate cancer patients undergoing radiotherapy.
Wilder RB; Barme GA; Gilbert RF; Holevas RE; Kobashi LI; Reed RR; Solomon RS; Walter NL; Chittenden L; Mesa AV; Agustin JK; Lizarde J; Macedo JC; Ravera J; Tokita KM
Brachytherapy; 2011; 10(1):44-50. PubMed ID: 20591748
[TBL] [Abstract][Full Text] [Related]
34. Prospective assessment of urinary, gastrointestinal and sexual symptoms before, during and after image-guided volumetric modulated arc therapy for prostate cancer.
Sveistrup J; Widmark A; Fransson P; Iversen P; Munck Af Rosenschöld P; Engelholm SA; Petersen PM
Scand J Urol; 2015 Feb; 49(1):58-69. PubMed ID: 24793783
[TBL] [Abstract][Full Text] [Related]
35. Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer.
Dess RT; Jackson WC; Suy S; Soni PD; Lee JY; Abugharib AE; Zumsteg ZS; Feng FY; Hamstra DA; Collins SP; Spratt DE
Cancer; 2017 May; 123(9):1635-1642. PubMed ID: 28001303
[TBL] [Abstract][Full Text] [Related]
36. High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer.
Patel S; Demanes DJ; Ragab O; Zhang M; Veruttipong D; Nguyen K; Park SJ; Marks L; Pantuck A; Steinberg M; Kamrava M
Brachytherapy; 2017; 16(2):299-305. PubMed ID: 27965117
[TBL] [Abstract][Full Text] [Related]
37. International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer.
van Leeuwen M; Kieffer JM; Efficace F; Fosså SD; Bolla M; Collette L; Colombel M; De Giorgi U; Holzner B; van de Poll-Franse LV; van Poppel H; White J; de Wit R; Osanto S; Aaronson NK; ; ;
Health Qual Life Outcomes; 2017 May; 15(1):97. PubMed ID: 28490338
[TBL] [Abstract][Full Text] [Related]
38. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.
Nout RA; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Stenfert Kroese MC; van Bunningen BN; Smit VT; Nijman HW; van den Tol PP; Creutzberg CL
J Clin Oncol; 2009 Jul; 27(21):3547-56. PubMed ID: 19546404
[TBL] [Abstract][Full Text] [Related]
39. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer.
van Andel G; Bottomley A; Fosså SD; Efficace F; Coens C; Guerif S; Kynaston H; Gontero P; Thalmann G; Akdas A; D'Haese S; Aaronson NK
Eur J Cancer; 2008 Nov; 44(16):2418-24. PubMed ID: 18774706
[TBL] [Abstract][Full Text] [Related]
40. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
